Solstein Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Solstein Capital's WST Position: Q3 2026 in Review
Solstein Capital sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 34 shares — an estimated $12.2K sold.
Solstein Capital first reported a position in WST in Q4 2019 and held it in 24 quarters. The position peaked at $24K in Q1 2020. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Solstein Capital reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Solstein Capital sold 34 West Pharmaceutical shares in Q3 2026, an estimated $12.2K.
- Solstein Capital first reported a position in West Pharmaceutical in Q4 2019 and held it in 24 quarters.
- Solstein Capital's West Pharmaceutical position peaked at $24K in Q1 2020.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Solstein Capital's 13F filing for Q3 2026, filed 2 Nov 2026.